Managing Acute PE: Updates from the 2026 AHA/ACC Guideline
Mary Leuchars, MD
Mark Creager, MD
Moving Toward Precision Medicine in PAH
Stephen Y. Chan, MD, PhD, FAHA
What’s Next for Pulmonary Arterial Hypertension Care?
Macitentan in Pediatric PAH: Results from the TOMORROW Trial
AI in Pulmonary Hypertension Demonstrates Progress—with Caveats
Targeting the Hippo Pathway in Pulmonary Arterial Hypertension
Ryan Quigley
Multi-Omics Brings New Clarity to the REHAB-PH Trial
Athlete-Focused CPET: Interpreting Physiology Beyond Standardized Testing
Benjamin Levine, MD, FACC
Understanding CPET for Athletes: Protocols and Pitfalls
Bringing PAH Care Home with Wearables and Telemedicine
Daniel Lachant, D.O.
Examining Barriers to Digital Healthcare in PAH
Leveraging Wearables for Pulmonary Arterial Hypertension Care
Targeting Macrophages in Pulmonary Arterial Hypertension
Reframing Palliative Care in PAH: Early Integration to Improve Outcomes
Fatty Acid Profiles May Be Linked to PAH Risk
Hidden HFpEF in Atrial Fibrillation: A Missed Diagnosis with Real Consequences
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Cardiology Academy… but how about a more personalized experience?
Press cancel to remain on Global Cardiology Academy. Press the link below or the continue button to keep going.